Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NewGam in adults with chronic primary immune thrombocytopenia
ISRCTN37539930Phase 3Completed
- Sponsor
- Octapharma
- Start
- Jun 2011
- Modality
- Recombinant Proteins and Enzymes
01
Overview
Phase 3, open-label trial of subcuvia in immune thrombocytopenia (ITP), sponsored by Octapharma. Started Jun 2011; status: completed.
02
Drugs
subcuvia
03
Conditions
immune thrombocytopenia (ITP)
Beyond the preview
Go deeper on ISRCTN37539930.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN37539930.